Literature DB >> 16565608

[Clinical experience of 48 acute toxic hepatitis patients].

Jeong Chul Seo1, Won Joong Jeon, Sung Soon Park, Seok Hyung Kim, Ki Man Lee, Hee Bok Chae, Seon Mee Park, Sei Jin Youn.   

Abstract

BACKGROUND/AIMS: Although many individual cases of toxic hepatitis have been reported in Korea, there are few comprehensive systematic studies on acute toxic hepatitis. The first aim of this study is to investigate the frequency and clinical characteristics of acute toxic hepatitis patients. The second aim of this study is to investigate the efficacy of steroid therapy for immunoallergic idiosyncrasy.
METHODS: Between March 1998 and March 2004 forty eight patients were included in this study. The medical records were reviewed retrospectively. Acute toxic hepatitis was diagnosed by score of more than 3 in RUCAM criteria. All the patients were tested for hepatitis A, B and C. Other tests included antibodies to CMV and EBV, ANA, AMA and SMA.
RESULTS: Seventy-three percent of the patients were female and the mean age of the patients was 47. Twenty cases of acute toxic hepatitis (42%) were related to prescribed medications. The other causes were herbs (35%) and traditional therapeutic preparations (23%). Common symptoms were jaundice (35%), fatigue (10%), fever (9%) and abdominal pain (9%). The biochemical pattern of hepatotoxicity was divided into three groups: hepatocellular (81%), mixed (13%), and cholestatic types (6%). Three patients who have prolonged and severe jaundice were classified into immunoallergic idiosyncrasy based upon clinical and histologic findings. Prednisolone was prescribed in all three cases whose bilirubin levels had been higher than 15 mg/dL for at least 7 days. Jaundice and the laboratory findings rapidly improved within 8 days since the treatment began.
CONCLUSIONS: In a demographic point of view, most patients of acute toxic hepatitis were middle aged women. Jaundice was the most commonly observed symptom. Prescribed drugs were the most common cause of acute toxic hepatitis. Although most cases of toxic hepatitis will recover with supportive care after cessation of the causative agent, steroid treatment may be helpful for the patients with severe jaundice patients who have immunoallergic idiosyncrasy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565608

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  2 in total

1.  Spontaneously reported hepatic adverse drug events in Korea: multicenter study.

Authors:  Hee Kwon; Suk-Hyang Lee; Seong-Eun Kim; Jae-Hyun Lee; Yung-Koo Jee; Hye-Ryun Kang; Byung-Joo Park; Jung-Won Park; Chein-Soo Hong
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

2.  Acute drug-induced hepatitis caused by albendazole.

Authors:  Gi Young Choi; Hyeon Woong Yang; Soung Hoon Cho; Dong Wook Kang; Hoon Go; Woong Chul Lee; Yun Jung Lee; Sung Hee Jung; An Na Kim; Sang Woo Cha
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.